Dr. Riccardo Cazzoli is a molecular pathologist and translational scientist specializing in innovative drug delivery technologies and cancer therapeutics. Dr. Cazzoli has an extensive track record in cancer biology, nanomedicine, and metabolic therapeutics, with high-impact publications and multiple patents. His research has been instrumental in advancing liquid biopsy diagnostics and novel therapeutic delivery systems, including industry collaborations with global leaders in cancer diagnostics and biotechnology.

His work focuses on overcoming major barriers in oncology, such as drug resistance and poor tumour targeting, with a particular emphasis on hard-to-treat cancers including triple-negative breast cancer and high-grade gliomas.